ArkBio
爱科百发arkbio
ArkBio
Biotech/Healthcare
Ark Biosciences is a biopharmaceutical company focused on developing innovative medicines, particularly antiviral therapies. In addition to its in-house R&D programs, the company actively in-licenses external drug candidates.
Latest round: Series D (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-07-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.